-
DNA ploidy, Stroma Fraction and Nucleotyping as potential predictive biomarkers for adjuvant Chemotherapy of stage II Colorectal Cancer: A Multicenter Cohort Study
AB-00116
-
1st line treatment strategies in BRAF-V600E mutation mCRC patients: a clinical experience and real-world data from a single center
AB-00127
-
Individualized Tumor-Informed Circulating Tumor DNA Analysis for Molecular Residual Disease Detection in Predicting Recurrence and Adjuvant Chemotherapy Efficacy in Colorectal Cancer
AB-0061
-
Review of Pseudomyxoma Peritoneii Treated by Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (CRS-HIPEC) , A Single Center Experience.
AB-00204
-
Measurement of CD8+ T cell-mediated anti-tumor immune response induced by neoadjuvant chemo-radiation therapy using T-cell receptor analysis in rectal cancer patient
AB-0014
-
Favorable long-term oncologic outcome of D3 lymph node dissection for clinical stage 2/3 right-sided colon cancer
AB-00157
-
Gut Microbiota Differences Between Colorectal Cancer Patients and Healthy Individuals: A Study in Central Taiwan
AB-00174
-
POLYREEN: A LOCALLY DEVELOPED ARTIFICIAL INTELLIGENCE SYSTEM FOR ENDOSCOPIC AUTOMATIC COLORECTAL POLYP DETECTION IN SARAWAK.
AB-00181
-
Patient-derived Organoids from BRAFV600E-Mutated Colorectal Cancer Can Capture Tumor Heterogeneity and Direct Personalized Therapy
AB-00115
-
Management of Malignant Rectal Polyps with Close Post-Polypectomy Margins Followed by Formal Total Mesorectal Excision – A Review of Local Experience
AB-00136